Fibroblast growth factor receptor 1 ( FGFR1 ; CD331 ), FGFR2 and fibroblast growth factor 19 ( FGF19 ) amplification may help predict sensitivity to FGFR inhibitors in cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.